Trials / Completed
CompletedNCT02149602
A Phase II Study of Parotid-gland Sparing IMRT in Patients With Midline Tumour of the Head and Neck
A Phase II Study of Parotid-gland Sparing Intensity-modulated Radiotherapy in Patients With Midline Tumour of the Head and Neck
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (actual)
- Sponsor
- Royal Marsden NHS Foundation Trust · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a phase II trial designed to test the feasibility of delivering IMRT to head and neck cancer patients with tumours arising in the midline (oropharynx and hypopharynx), and to assess possible improvement in reducing the incidence of xerostomia with bilateral superficial lobe parotid sparing IMRT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Intensity modulated radiotherapy | Bilateral superficial lobe parotid sparing intensity modulated radiotherapy |
Timeline
- Start date
- 2005-07-01
- Primary completion
- 2011-11-01
- Completion
- 2014-01-01
- First posted
- 2014-05-29
- Last updated
- 2014-05-29
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02149602. Inclusion in this directory is not an endorsement.